[
  {
    "ts": null,
    "headline": "TD Cowen Lifts CVS Health Corporation (CVS) Price Target amid Record Q3 Revenue",
    "summary": "CVS Health Corporation (NYSE:CVS) is one of the best blue-chip stocks to buy now. On November 3, 2025, TD Cowen lifted its price target on the stock to $100 from $99, while keeping a Buy rating. The move followed management’s updated guidance, which narrowed the expected GAAP diluted loss per share to between $0.24 and […]",
    "url": "https://finnhub.io/api/news?id=7378138b3fa5f0937882541b13a767abcfb6c494d5c19e1710312266f14b06d1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763182240,
      "headline": "TD Cowen Lifts CVS Health Corporation (CVS) Price Target amid Record Q3 Revenue",
      "id": 137486781,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health Corporation (NYSE:CVS) is one of the best blue-chip stocks to buy now. On November 3, 2025, TD Cowen lifted its price target on the stock to $100 from $99, while keeping a Buy rating. The move followed management’s updated guidance, which narrowed the expected GAAP diluted loss per share to between $0.24 and […]",
      "url": "https://finnhub.io/api/news?id=7378138b3fa5f0937882541b13a767abcfb6c494d5c19e1710312266f14b06d1"
    }
  }
]